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Abstract: The volume of total hip (THA) and knee arthroplasties (TKA) performed in a hospital per
year could be an influential factor on the revision of these procedures. The aims of this study were:
To obtain comparable cohorts in higher- and lower-volume hospitals; and to assess the association
between the hospital volume and the incidence of revision. Data from patients undergoing THA and
TKA caused by osteoarthritis and recorded in the Catalan Arthroplasty Register (RACat) between
January 2005 and December 2016 were used. The main explanatory variable was hospital volume by
year (higher/lower). The cut-off point was fixed, based on previous research, at 50 THA and 125 TKA
procedures/year. To obtain comparable populations, a propensity-score matching method (1:1) was
used. Patient characteristics prior to and after matching were compared. To assess differences by
volume, subhazard ratios (SHRs) from competing risks models were obtained. After matching,
13,772 THA and 36,316 TKA patients remained in the study. Prior to matching, in both joints,
significant differences in all confounders were observed between volume groups. After matching,
none of them remained significant. Both in THA and TKA, a higher risk of revision in higher-volume
hospitals was observed (THA SHR: 1.25, 95%CI: 1.02–1.53; and TKA SHR: 1.29, 95%CI: 1.16–1.44).
Unlike other contexts, currently in Catalonia, higher-volume hospitals have a greater risk of revision
than lower-volume hospitals. Further research could be valuable to define context-dependent
measures to reduce the incidence of revision.
Keywords: total hip arthroplasty; total knee arthroplasty; hospital volume; revision; register studies
1. Introduction
In recent years, several studies have highlighted some specific risk factors for revision surgery in
total hip and knee arthroplasties (THA and TKA), including patient factors like sex, age or comorbidity;
intervention factors like type of prosthesis or type of fixation; and hospital factors like the circumstances
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of admission or the number of procedures performed each year [1,2]. The relationship between some
of these variables and the risk of revision is clear and consistently found in gender, age and the year
the primary procedure was performed [3–5]. Nevertheless, the relationship with some hospital and
healthcare related variables remains unclear. Due to the possible relationship to the THA and TKA
revision, the number of procedures performed per year by the hospital or hospital volume by year has
been pointed out [6,7].
Previous studies have shown varying results when examining the relationship between the
hospital volume by year and the risk of revision but after focusing on these results, the evidence
found is inconsistent [6–15]. While some of them have not found any association between the hospital
volume and the risk of revision [9–11], other studies have suggested a possible higher risk of revision
for primary prostheses in lower volume hospitals over higher volume, both at medium- and long-term
follow-up [6,7,12–14]. Differences in the results previously found might be related to the context of
the study. As mentioned in prior research, an explanation for the difference in results could be the
possible case-mix between volume groups [8,16], meaning the characteristics of patients undergoing
an arthroplasty could vary between hospital volume groups. Therefore, it could be advantageous to
take this possibility into account to obtain a more accurate representation of how the volume by year
could be related to the incidence of revision in THA and TKA.
Regarding the methodology used in the aforementioned studies, most of them were performed
without matching cohorts from different volume groups. Due to differences in the characteristics of
patients between volume groups, the conclusions drawn from these cohorts might not be comparable.
As such, using propensity scores in the last few years to match different populations has become
popular [16,17]. These scores might allow comparable cohorts to be acquired and could reduce the
bias when comparing the results between them.
Therefore, the aims of this study were: (1) To obtain comparable cohorts in higher and lower
volume hospitals and (2) to assess the association between the THA and TKA volume by year and the
incidence of revision at one, five and 10 years in Catalonia.
2. Experimental Section
2.1. Design and Study Population
A prospective observational design based on data from the Catalan Arthroplasty Register (RACat)
and the Minimum Basic Dataset at hospital discharge (MBD-HD) was drawn up. The RACat is
a population-based arthroplasty register that has collected data about hip and knee arthroplasties
performed in Catalonia since 2005. The RACat includes 53 out of 61 public hospitals in Catalonia with
approximately 830 surgeons performing hip and knee arthroplasties. The completeness of the RACat
is about 90% for primary arthroplasties and about 70% for revision procedures [18]. The MBD-HD is
a mandatory, payment-related health database that includes information about the patient and the
surgical procedure, like diagnosis (including ICD-9-CM codes) and the reason for intervention and
revision. The MBD-HD dataset is merged with the RACat dataset using a common identification
number as well as other variables like surgery date and hospital admission and discharge dates.
Furthermore, and given its mandatory nature, the MBD-HD is used as a standard to calculate the
completeness of the RACat.
The study population included all patients undergoing a THA (conventional) or a TKA (including
cruciate retaining and posterior stabilized) caused by osteoarthritis and recorded in the Catalan
Arthroplasty Register (RACat) between January 2005 and December 2016. In total, the present study
includes 18,283 patients undergoing THA and 45,553 TKA. After matching, a total of 13,772 THA from
46 hospitals (Figure 1) and 36,316 TKA from 49 hospitals (Figure 2) remained in the study.
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2.2. Study Variables
The main outcome considered in this study was the revision of the primary arthroplasty. A revision
procedure is defined within the RACat, both for THA and TKA, as any procedure involving removal,
exchange or addition of any implant component.
The volume of THA and TKA procedures performed by year in the hospitals participating in
the RACat during the study period was taken as the main exploratory factor. The hospital volume
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was considered as a dichotomous variable (higher/lower), based both on the cut-off values fixed on
previous research on this topic [6,7,12], and on the number of THA and TKA procedures performed
by year in the Catalan hospitals. For THA, hospitals performing fewer than 50 procedures per year
were considered low-volume hospitals. For TKA, hospitals performing fewer than 125 procedures
per year were considered low-volume hospitals. A hospital could provide cases to either the high- or
low-volume group, depending on the number of procedures performed in a specific year.
The following confounders were considered: Sex (men and women), age (<65, 65–74, 75–84,
and ≥85 years old), comorbidity on the Elixhauser index (no comorbidity, one or two comorbidities,
and three or more comorbidities), year of intervention (2005/2007, 2008/2010, 2011/2013, and 2014/2016)
and type of fixation (cemented, cementless, hybrid, reverse hybrid, and not specified).
2.3. Data Analysis
Descriptive analyses of THA and TKA populations pre- and post-matching were performed,
and differences were tested using Chi-Square tests. To select comparable populations, a propensity
score matching method 1:1 was used, considering hospital volume as the exposure and sex, age,
comorbidity, year of intervention and type of fixation as confounders. The incidence of revision at
one, five and 10 years was obtained using the Kaplan–Meier method taking the competing risk of
death into account. The incidence of revision was estimated by calculating t S(t−1) × h’(t), where
S(t−1) is the Kaplan–Meier estimate of the overall survival function and h’(t) is the cause-specific
hazard at time t. In addition, to evaluate differences in risk of revision, competing risks models were
fitted, considering death as the competing event and hospital volume as the main exposure. From
these models, subhazard ratios (SHRs) for revision and their 95% confidence intervals (95% CI) were
obtained. All models and all analyses were stratified by the joint operated on. The significance level
was fixed at α = 0.05 and all analyses were performed using Stata version 14 [19].
3. Results
In total, 11,132 patients undergoing THA in 28 higher-volume hospitals and 7151 from 46
lower-volume hospitals were included (Table 1). In terms of TKA, a total of 24,683 patients from 30
higher-volume hospitals and 20,870 from 49 lower-volume hospitals were included (Table 2). After
matching, 6886 patients undergoing THA and 18,158 undergoing TKA for each volume group remained
in the study. Prior to matching, both for THA and TKA, statistically significant differences (p < 0.05)
in all confounders (sex, age, comorbidity on the Elixhauser index, year of intervention and type of
fixation) between higher- and lower-volume groups were observed. After matching, none of these
differences remained significant.











n % n % p n % n % p
Sex 0.044 0.495
Men 5,439 48.86 3,603 50.38 3,426 49.75 3,466 50.33
Women 5,693 51.14 3,548 49.62 3,460 50.25 3,420 49.67
Age 0.015 0.416
<65 3,317 29.80 2,047 28.63 2,014 29.25 2,001 29.06
65–74 3,822 34.33 2,464 34.46 2,331 33.85 2,372 34.45
75–84 3,562 32.00 2,408 33.67 2,287 33.21 2,293 33.30
≥85 431 3.87 232 3.24 254 3.69 220 3.19
Comorbidity (Elixhauser) 0.020 0.821
no comorbidity 4,351 39.09 2,65 37.06 2,565 37.25 2,583 37.51
1–2 comorbidities 5,8 52.10 3,866 54.06 3,723 54.07 3,690 53.59
3 or more comorbidities 981 8.81 635 8.88 598 8.68 613 8.90











n % n % p n % n % p
Year of intervention 0.993
2005/2007 982 8.82 1,116 15.61 875 12.71 868 12.61
2008/2010 2,999 26.94 2,038 28.50 2,025 29.41 2,035 29.55
2011/2013 3,871 34.77 2,253 31.51 2,258 32.79 2,248 32.65
2014/2016 3,280 29.46 1,744 24.39 1,728 25.09 1,735 25.20
Type of fixation <0.001 0.700
Cemented 906 8.14 719 10.05 666 9.67 636 9.24
Cementless 7,561 67.92 4,93 68.94 4,762 69.15 4,786 69.50
Hybrid 2,512 22.57 1,397 19.54 1,388 20.16 1,384 20.10
Reverse hybrid 106 0.95 93 1.30 70 1.02 80 1.16
Not specified 47 0.42 12 0.17 . . . .
Number of hospitals 28 46 28 46
Median follow-up (IQR) 4.6 (4.5) 4.8 (4.7)
Higher volume: Fifty or more procedures per year in total hip arthroplasty and 125 or more procedures per year
in total knee arthroplasty; n: number of patients; %: Percentage of patients; p: p value based on Chi-Square tests;
comorbidity (Elixhauser): Number of comorbidities from Elixhauser index.











n % n % p n % n % p
Sex <0.001 0.709
Men 6,971 28.24 6,220 29.80 5,140 28.31 5,108 28.13
Women 17,712 71.76 14,65 70.20 13,018 71.69 13,050 71.87
Age <0.001 0.950
<65 4,02 16.29 3,608 17.29 3,117 17.17 3,157 17.39
65–74 10,747 43.54 9,151 43.85 8,015 44.14 7,976 43.93
75–84 9,363 37.93 7,767 37.22 6,729 37.06 6,729 37.06
≥85 553 2.24 344 1.65 297 1.64 296 1.63
Comorbidity (Elixhauser) <0.001 0.886
no comorbidity 6,633 26.87 6,533 31.30 5,154 28.38 5,115 28.17
1–2 comorbidities 14,871 60.25 12,01 57.55 10,860 59.81 10,904 60.05
3 or more comorbidities 3,179 12.88 2,327 11.15 2,144 11.81 2,139 11.78
Year of intervention <0.001 0.756
2005/2007 2,994 12.13 3,287 15.75 2,328 12.82 2,388 13.15
2008/2010 6,846 27.74 6,097 29.21 5,493 30.25 5,428 29.89
2011/2013 7,136 28.91 6,36 30.47 5,711 31.45 5,700 31.39
2014/2016 7,707 31.22 5,126 24.56 4,626 25.48 4,642 25.56
Type of fixation <0.001 0.292
Cemented 18,901 76.57 16,769 80.35 15,619 86.02 15,616 86.00
Cementless 205 0.83 152 0.73 91 0.50 148 0.82
Hybrid 3,491 14.14 2,545 12.19 2,421 13.33 2,367 13.04
Reverse hybrid 184 0.75 30 0.14 27 0.15 27 0.15
Not specified 1,902 7.71 1,374 6.58 . . .
Number of hospitals 30 49 30 49
Median follow-up (IQR) 4.8 (5.0) 4.9 (4.7)
Higher volume: Fifty or more procedures per year in total hip arthroplasty and 125 or more procedures per year in
total knee arthroplasty; n: Number of patients; %: Percentage of patients; p: p value based on Chi-Square tests;
comorbidity (Elixhauser): Number of comorbidities from Elixhauser index.
In THA, the most frequent causes of revision were aseptic loosening (n = 70, 33.7%), infection
(n = 48, 23.1%), dislocation (n = 33, 15.9%) and mechanical complications (n = 30, 14.4%) for the
higher-volume group, and aseptic loosening (n = 48, 28.4%), dislocation (n = 46, 27.2%), mechanical
complications (n = 25, 14.8%) and infection (n = 23, 13.6%) for the lower-volume group. In addition,
Figure 3 shows the cumulative incidence of revision in THA by the volume group and the magnitude
of the differences in the risk of revision between volume groups in THA. The cumulative incidence
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of revision was 1.31% (95% CI: 1.06–1.61), 2.85% (95% CI: 2.45–3.31) and 4.61% (95% CI: 3.88–5.43)
at one, five and 10 years’ follow-up in patients operated on in the higher-volume group hospitals
and 0.97% (95% CI: 0.76–1.23), 2.32% (95% CI: 1.95–2.74) and 3.63% (95% CI: 3.06–4.27), respectively
in patients from lower-volume hospitals. Taking the differences in the risk of revision into account
(Table 3), a higher risk of revision was observed in higher-volume hospitals than in lower-volume
hospitals (SHR: 1.25, 95% CI: 1.02–1.53).
Table 3. Cumulative revision and differences by hospital volume of procedures by year in total hip
arthroplasty (THA). RACat 2005–2016.
Time (in Years) At Risk Revisions Cum. Failure (95% CI) SHR (95% CI)
Lower volume 1.00
1 6,258 66 0.97 (0.76–1.23)
5 3,353 70 2.32 (1.95–2.74)
10 352 32 3.63 (3.06–4.27)
Higher volume 1.25 (1.02–1.53)
1 6,239 89 1.31 (1.06–1.61)
5 3,214 82 2.85 (2.45–3.31)
10 389 36 4.61 (3.88–5.43)
At risk: Number of primary procedures at the beginning of the period. Revisions: Number of revision procedures
during the period; cum. failure: Cumulative failure; (95% CI): 95% confidence interval. SHR: Subhazard ratio for the
hospital volume (Lower volume as reference category) adjusted for sex, age, comorbidity (from Elixhauser index),
year of intervention and type of fixation.
J. Clin. Med. 2019, 8, x FOR PEER REVIEW 6 of 11 
 
of the differences in the risk of revision between volume groups in THA. The cumulative incidence 
of revision was 1.31% (95% CI: 1.06–1.61), 2.85% (95% CI: 2.45–3.31) and 4.61% (95% CI: 3.88–5.43) at 
one, five and 10 years’ follow-up in patients operated on in the higher-volume group hospitals and 
0.97% (95% CI: 0.76–1.23), 2.32% (95% CI: 1.95–2.74) and 3.63% (95% CI: 3.06–4.27), respectively in 
patients from lower-volume hospitals. Taking the differences in the risk of revision into account 
(Table 3), a higher risk of revision was observed in higher-volume hospitals than in lower-volume 
hospitals (SHR: 1.25, 95% CI: 1.02–1.53).  
Table 3. Cumulative revision and differences by hospital volume of procedures by year in total hip 
arthroplasty (THA). RACat 2005–2016. 
Time (in years) At risk Revisions Cum. Failure (95% CI) SHR (95% CI) 
Lower volume    1.00 
1 6,258 66 0.97 (0.76–1.23)  
5 3,353 70 2.32 (1.95–2.74)  
10 352 32 3.63 (3.0 4.27)  
Higher volume    1.25 (1.02–1.53) 
1 6,239 89 1.31 (1.06–1.61)  
5 3,214 82 2.85 (2.45 3.31)  
10 389 36 4.61 (3.88–5.43)  
At risk: Number of primary procedures at the beginning of the period. Revisions: Number of revision 
procedures during the period; cum. failure: Cumulative failure; (95% CI): 95% confidence interval. 
SHR: Subhazard ratio f r th  hospital volume (Lower volume as reference category) adjusted for s , 
age, comorbidity (from Elixhauser index), year of intervention and type of fixation. 
 
Figure 3. Cumulative revision in total hip arthroplasty (THA). 
Regarding TKA, the most frequent causes of revision were mechanical complications (n = 254, 
35.7%), aseptic loosening (n = 233, 32.7%), infection (n = 152, 21.4%) and dislocation (n =16, 2.3%) for 
the higher-volume group, and aseptic loosening (n = 252, 44.8%), mechanical complications (n = 137, 
24.4%), infection (n = 88, 15.7%) and dislocation (n = 14, 2.5%) for the lower-volume group. 
Additionally, the cumulative incidence of revision (Figure 4) was 1.15% (95% CI: 1.00–1.32) at one 
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Figure 3. Cumulative revision in total hip arthroplasty (THA).
Regarding TKA, the most frequent causes of revision were mechanical complications (n = 254,
35.7%), aseptic loosening (n = 233, 32.7%), infection (n = 152, 21.4%) and dislocation (n =16, 2.3%) for
the higher-volume group, and aseptic loosening (n = 252, 44.8%), mechanical complications (n = 137,
24.4%), infection (n= 88, 15.7%) and dislocation (n= 14, 2.5%) for the lower-volume group. Additionally,
the cumulative incidence of revision (Figure 4) was 1.15% (95% CI: 1.00–1.32) at one year, 4.17% (95%
CI: 3.85–4.50) at five years’ and 5.8% (95% CI: 5.33–6.39) at 10 years’ follow-up for the higher-volume
group, and 0.64% (95% CI: 0.53–0.77), 3.24% (95% CI: 2.96–3.53) and 4.7% (95% CI: 4.21–5.13) for the
lower-volume group. After examining the differences in risk of revision in TKA (Table 4), a significant
higher risk of revision was observed when the volume by year was higher than when it was lower
(SHR: 1.29, 95% CI: 1.16–1.44).
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Table 4. Cumulative revision and differences by hospital volume of procedures by year in total knee
arthroplasty (TKA). RACat 2005–2016.
Time (in Years) At Risk Revisions Cum. Failure (95% CI) SHR (95% CI)
Lower volume 1.00
1 16,594 112 0.64 (0.53–0.77)
5 9,064 366 3.24 (2.96–3.53)
10 1,217 80 4.66 (4.21–5.13)
Higher volume 1.29 (1.16–1.44)
1 16,293 202 1.15 (1.00–1.32)
5 8,673 422 4.17 (3.85–4.50)
10 744 89 5.84 (5.33–6.39)
At risk: Number of primary procedures at the beginning of the period. Revisions: Number of revision procedures
during the period; cum. failure: Cumulative failure; (95% CI): 95% confidence interval. SHR: Subhazard ratio for the
hospital volume (Lower volume as reference category) adjusted for sex, age, comorbidity (from Elixhauser index),
year of intervention and type of fixation.
J. Clin. Med. 2019, 8, x FOR PEER REVIEW 8 of 11 
 
Table 4. Cumulative revision and differences by hospital volume of procedures by year in total knee 
arthroplasty (TKA). RACat 2005–2016. 
Time (in years) At risk Revisions Cum. Failure (95% CI) SHR (95% CI) 
Lower volume    1.00 
1 16,594 112 0.64 (0.53–0.77)  
5 9,064 366 3.24 (2.96–3.53)  
10 1,217 80 4.66 (4.21–5.13)  
Higher volume    1.29 (1.16–1.44) 
1 16,293 202 1.15 (1.00–1.32)  
5 8,673 422 4.17 (3.85 4.50)  
10 744 89 5.84 (5.33 6.39)  
At risk: Number of primary procedures at the beginning of the period. Revisions: Number of revision 
procedures during the period; cum. failure: Cumulative failure; (95% CI): 95% confidence interval. 
SHR: Subhazard ratio for the hospital volume (Lower volume as reference category) adjusted for sex, 
age, comorbidity (from Elixhauser index), year of intervention and type of fixation. 
 
Figure 4. Cumulative revision in total knee arthroplasty (TKA). 
4. Discussion 
Our study overcomes a few methodological limitations of previous research and shows that, 
nowadays in Catalonia, the volume of THA and TKA procedures performed in a hospital per year 
could be related to the incidence of revision. Contrary to previous research focused on other contexts 
carried out using unmatched cohorts [6,7,12–14], higher-volume hospitals could have a higher risk of 
revision in their primary prostheses than lower-volume centers in Catalonia.  
Some studies that have analyzed the relationship between the volume of THA and TKA 
procedures by year and the risk of revision, have not found any relationship between them [9,11]. 
Nevertheless, recent research carried out with large samples at the national level [6,7,12], both for 
THA and TKA, have reported results that suggest a higher risk of revision in patients operated on in 
lower-volume hospitals than in higher-volume hospitals. In this sense, both the study performed with 
more than 40,000 THA, based on the Nordic Arthroplasty Register Association database [7], and a 
study with more than 25,000 TKA from Norway [12], suggest that lower-volume hospitals might have 
an increased long-term risk of revision. Our results were contradictory to this hypothesis, showing 
an opposite association between the annual hospital THA volume and long-term risk of revision.  
As far as we know, only one previous study has found a slightly higher risk of revision in higher-
volume hospitals [8]. While the authors of that study hypothesized that their results could be caused 
Figure 4. Cumulative revision in total knee arthroplasty (TKA).
4. Discussion
O r study overcomes a few methodological limitations of previous research and shows that,
nowadays in Catalonia, the volume of THA and TKA procedures performed in a hospital per year
could be related to the incidence of revision. Contrary to previous research focused on other contexts
carried out using unmatched cohorts [6,7,12–14], higher-volume hospitals could have a higher risk of
revision in their primary prostheses than lower-volume centers in Catalonia.
Some studies that have analyzed the relationship between the volume of THA and TKA procedures
by year and the risk of revision, have not found any relationship between them [9,11]. Nevertheless,
recent research carried out with large samples at the national level [6,7,12], both for THA and TKA,
have reported results that suggest a higher risk of revision in patients operated on in lower-volume
hospitals than in higher-volume hospitals. In this sense, both the study performed with more than
40,000 THA, based on the Nordic Arthroplasty Register Association database [7], and a study with
more than 25,000 TKA from Norway [12], suggest that lower-volume hospitals might have an increased
long-term risk of revision. Our results were contradictory to this hypothesis, showing an opposite
association between the annual hospital THA volume and long-term risk of revision.
As far as we know, only one previous study has found a slightly higher risk of revision in
higher-volume hospitals [8]. While the authors of that study hypothesized that their results could be
caused by a possible case-mix between volume groups, our study has similar results after overcoming
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this issue by using propensity-score matched cohorts [16,17]. These results, at least in Catalonia, could
be partially explained by factors related to the healthcare organization. Higher-volume hospitals
are usually centers that have residents, students in training and more healthcare personnel than
lower-volume hospitals. That said, in higher-volume hospitals it is usually much more difficult to deal
with environmental factors that might be a potential cause of infection, as was suggested by our results
about the causes of revision by the volume group. Additionally, patients from higher-volume hospitals
might have been operated on by a surgical trainee, a factor that could be related to higher revision rates
due to the learning curve [8,20,21]. In the lower-volume hospitals in Catalonia, usually only one surgeon
performs each type of arthroplasty. Due to this, despite the lower volume by hospital, the volume by
surgeon could be high, a factor that has been related to lower revision rates [13,14,22]. Further research
using matched cohorts from different healthcare contexts, e.g., using data from different countries’ or
cultures’ registers, using different cut-off values to divide between higher- and lower-volume groups,
and accounting for surgeon and hospital-environment related variables, could help improve our
understanding of how volume by year is related to the incidence of revision. Depending on the context,
this knowledge might help define specific healthcare organizational measures in an attempt to reduce
the burden of revision in THA and TKA.
There are some limitations in this study that need to be discussed. First, the completeness of
primary THA in the RACat is not 100%, especially during the first years of its implementation, and it
is possible that not all primary and revision procedures were reported in those years. However,
no disparity in collecting revisions between high- and low-volume hospitals was observed [18].
Furthermore, the number of prostheses with a follow-up of 10 years is very low but this trend may
change in the future. Regarding the specific prosthesis model or brand used in the different hospitals,
due to limitations in the robustness and validity of the estimations related to differences between
hospitals in their use and to the small sample size of some of these models, this potential confounder
was not included. Future research with larger sample sizes accounting for this factor could be valuable
in obtaining a more precise representation of how the volume by year affects the outcomes in THA
and TKA. Another limitation is the fixed cut-off point to differentiate higher- and lower-volume
groups. This variable could be taken as a continuous variable or changed to include a larger number
of categories based on different cut-off values. Despite this, these cut-off points were based on those
used in previous research with similar aims [6,7,12] and dichotomized due to the low number of
patients in some categories after we tested it as a five- and three-category variable. Furthermore, the
dichotomization allows us to match the higher- and lower-volume cohorts, making them comparable
within the confounders included. In addition, the crossover between hospital volume groups was
not taken into account. Nevertheless, as observed in hospitals participating in the RACat [18], this
change of the volume group was, in most cases, an increasing or decreasing trend of hospital activity.
Finally, due to the data captured in the RACat, it is important to indicate that we studied the hospital
volume and not surgeon volume, which may influence our estimates. Furthermore, there is a lack of
surgeon-related data and the number of surgeons by hospital is unknown, which are factors that could
have a mediating effect between the volume and the risk of revision. In addition, we only considered
primary procedure revisions, not other outcomes like patient reported outcome measures (PROMs).
Nevertheless, it is important to mention that these limitations could be overcome in the upcoming
years because the RACat has been mandatory since 2017, and is beginning to capture surgeon data as
well as data on other variables and outcomes like PROMs.
In conclusion, our study shows that hospitals performing a higher volume of arthroplasties in
Catalonia have an increased risk of revision due to all causes, compared to low-volume hospitals.
Further research taking other variables into account and involving registers from different countries
could be valuable to better understand this relationship and define specific context-dependent measures
to try to reduce the incidence of revision in both THA and TKA.
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